chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In the right hand, the point finger with hematoma; Red eye; Arm pain; Pain in the front chest; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), CHEST PAIN (Pain in the front chest), OCULAR HYPERAEMIA (Red eye) and HAEMATOMA (In the right hand, the point finger with hematoma) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain) and CHEST PAIN (Pain in the front chest). On 01-Feb-2021, the patient experienced OCULAR HYPERAEMIA (Red eye). On 03-Feb-2021, the patient experienced HAEMATOMA (In the right hand, the point finger with hematoma). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and HYDROXYZINE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain), CHEST PAIN (Pain in the front chest), OCULAR HYPERAEMIA (Red eye) and HAEMATOMA (In the right hand, the point finger with hematoma) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter.
aching from head to toe; overslept; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aching from head to toe) and HYPERSOMNIA (overslept) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID vaccine. Past adverse reactions to the above products included No adverse event with Pfizer COVID vaccine.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (aching from head to toe) and HYPERSOMNIA (overslept). At the time of the report, PAIN (aching from head to toe) and HYPERSOMNIA (overslept) had resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   No concomitant medications were provided.  It was reported that after vaccine was aching from head to toe, overslept and felt out of it for a couple days.   No treatment information was provided.  Company comment: This spontaneous case concerns a patient of unknown age and gender, with no medical history information reported, who experienced the unexpected non serious AESI of hypersomnia and non serious event of pain. The events occurred after a dose of SPIKEVAX 2023-2024. As reported, after receiving vaccine patient was aching from head to toe, overslept and felt "out of it" for a couple days. No further information about the events was provided. The benefit-risk relationship of SPIKEVAX 2023-2024 is not affected by this report.
Normal delivery on 9/30/2021. Hospital admission was within 6 weeks of receiving the COVD vaccine.
covid; Flu; Initial information received on 09-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and gender patient who experienced covid and flu while receiving vaccine Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza vaccine produced by unknown manufacturer (lot number, expiry date: not reported) via unknown route in unknown administration site (form, strength: unknown) for flu.  On an unknown date the patient developed non-serious events of covid (covid-19) and flu (influenza) (unknown latency) following the administration of Influenza vaccine.  Action taken- Not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for both the events.
The patient is a 25 y/o male.  He was given a smallpox vaccination which developed a local cellulitis after he had applied double band aids to the vaccination site.  He followed up at the MTF when an infection had developed.  He was seen by the Doctor who prescribed TRIMOXAZOLE for 10 days and cellulitis cleared, but patient developed a local reaction to the band aids.
This spontaneous report as received from a health care worker refers to a currently 17 years old female patient with drug hypersensitivity to acetaminophen, VICODIN. The patient was vaccinated with dose 1 GARDASIL (lot #, dose and route not reported) over 5 years ago. No other co-suspects were and no concomitant medications were reported. The health care worker reported that the patient fainted in the physician's office after receiving the first dose of vaccine. This did not occur at the reported physician's office. No treatment information was reported. The patient sought medical attention while she was still at the physician's office. The outcome of fainted in the physician's office after receiving first dose of vaccine was reported as recovered on an unspecified date. The relatedness for the reported event was not provided for GARDASIL. Additional information is not expected.
8/31/21 pt tested positive for COVID; lives in nursing home;  9/5/21 EMS called to nursing home due to pt being unresponsive; found to have agonal respirations, hypotension; was intubated and brought to hospital; given IV ABX; pt was to come out of quarantine today; family decided on comfort measures only; pt extubated and she expired in the hospital
CONFUSED FEELING; ELEVATED BLOOD PRESSURE 150/100; TACHYCARDIA/RACING HEART; DIARRHEA; WHOLE BODY ACHES; DIZZINESS/LIGHT HEADEDNESS/FELT FAINT; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 38 year old not Hispanic or Latino, White female. The patient's weight was 135 pounds, and height was 60 inches. The patient's concurrent conditions included thalassemia, no alcohol use, and non smoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage. Patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 09-JUN-2021) dose was not reported, frequency once total administered on 05-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the patient experienced dizziness/light headedness/felt faint,  whole body aches, fever, headache. On 07-APR-2021, the patient then experienced tachycardia/racing heart and diarrhea, called 911 and had elevated blood pressure 150/100 and referred to cardiologist. On 08-APR-2021, the patient experienced confused feeling. Laboratory data included: Blood pressure (NR: not provided) 150/100 mmHg, complete blood count (NR: not provided) autolymphocytes numer 0.91, WBC 4.59, red cell distribution width 17.4 me, Chest X-ray (NR: not provided) unknown, Creatinine (NR: not provided) 0.6, Electrocardiogram (NR: not provided) unknown, Echocardiogram (NR: not provided) unknown, Glucose (NR: not provided) 105, Hematocrit (NR: not provided) 34.9, Lymphocytes (NR: not provided) 19.8, Monocyte count (NR: not provided) 11.8, and Urinalysis (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from whole body aches, and fever on 06-APR-2021, was recovering from headache, and elevated blood pressure 150/100 , had not recovered from dizziness/light headedness/felt faint, diarrhea, and tachycardia/racing heart, and the outcome of  confused feeling was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20210420710- Covid-19 vaccine ad26.cov2.s-Elevated blood pressure 150/100. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
48 hours of intense chills, fever 101 degrees f, vomiting followed by days of abdominal cramping and diarrhea. Hasn?t stopped yet.
Extreme tiredness.  Difficult walking.  See Black for a few seconds at various times.  Short-term memory is very bad.   Feeling that arm (left) or legs are there but that they are not functioning correctly...   Heart had some pain on  9/30.
Narrative: COVID infection following COVID vaccine series 01/08, Pfizer, dose #1 01/29, Pfizer, dose #2 09/15 COVID swab, result: detected 09/15 pt cc: exposure; unknown 09/15 cc: dx: asymptomatic COVID-19 LOS: 2 DAYS 09/15 CXR impression: No acute cardiopulmonary disease. 09/16 CT chest impression: No acute focal airspace consolidation. Right basilar atelectasis/scarring.
This spontaneous report as received from a nurse refers to 52 patients of unknown age. On 17-DEC-2013 the nurse reported that 52 patients (demographics unspecified) were vaccinated with PNEUMOVAX23. Lot number and expiry date were reported as J011651 and 22-AUG-2014 respectively. Approximately on an unknown date in December 2013 (within 12 to 24 hours following vaccination) the patients developed injection site reactions, vomiting, nausea, fever, chills and headaches. Approximately on an unknown date in December 2013, the nurse reported that some of the patients (unspecified number) have missed 2 or three days of work (disability). Treatment given for adverse events included ALEVE and Ibuprofen. The outcome of missed 2 or 3 days of work, some vomiting, nausea, fever, chills, headaches and patients developed injection site reactions was reported as recovering/resolving. The nurse reported that some of the patients are recovering quicker than other patients, but all are expected to completely recover. Causality of events was unknown. This is one of the two reports received from the same reporter (#1312USA010905). Additional information has been requested.
Pt recv vax on 10/17/97; 15 min post vax pt exp fever, malaise, pain between shoulders, chills; on 10/18/97 pt passed out/ fever 103.8
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not known. One year ago, in approximately 2015, the patient was vaccinated with the first dose of either GARDASIL or GARDASIL 9. The patient would now like to receive a second dose of GARDASIL or GARDASIL 9 now, on 23-NOV-2016 (inappropriate schedule of drug administration). No adverse symptoms were reported. Additional information has been requested.
New onset systolic and diastolic heart failure. Malaise with intermittent nausea/diaphoresis.
Had vaccine.  Went Home; was okay until that evening.  Had  slight headache, tired achy so took 1 tylenol pm and went to bed. Woke up to to go bathroom and felt nauseous and light headed.  Went to bathroom was washing hands and room was spinning. Called for my  husband and he came to help hold me but a passed out, slipped out of his arms and landed on floor. I came to, he took my oxygen which was 77; fever of 100.  He put my oxygen on and got me to bed. Woke up next morning, nauseous all day, headache, and have a black eye from fall.  Felt tired but felt better the following day.
He got a positive diagnosis of COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (He got a positive diagnosis of COVID) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In September 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced SARS-COV-2 TEST POSITIVE (He got a positive diagnosis of COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (He got a positive diagnosis of COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test: positive (Positive) positive.         The patient wanted to reach out to someone about how "there should not be a covid patient driving their sample of saliva while they are sick." Concomitant medications were not provided. Treatment information was not reported.
More than (30) vesicular lesions on erythematous base scattered over trunk, face, (R) auricle & diaper area.
rare Guillain Barre syndrome; This is a spontaneous report from a contactable consumer (patient) based on the information received by Pfizer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced rare Guillain barre syndrome on an unspecified date. The patient was on the mend but cant take any vaccine for 12 months. The outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient presented to the ED for evaluation. Diagnosed with cellulitis of the upper right arm. Treatment in the ED consisted of oral antibiotics (Keflex and Bactrim) for infection, and opiods (Norco) for pain control.
Left deltoid cellulitis a site of smallpox vaccination. Resolving with IV ABX unk, x 2 doses and Augmentin 875 mg PO BID. Seen in ER after hours initially and for IV ABX. No admission, no issues now.
pt recv vax & devel an inj site rxn characterized by warmth, redness, & swelling;this is 1 of 4 pt from this site & lot# to report these adverse rxn;
patient reports throat and tongue itching and tongue swelling and scratchiness of her voice, admitted to EC and given Benadryl, Solumedrol, morphine, and discharged home on same day.
pt recvd vax; on 8dec95 in MD ofc w/ fever,"erythema of rt deltoid";swollen node on rt axilla;erythema was warm to touch;the shoulder & arm were tender but appeared to be mobile;reporting RN felt that pt's exp was life threatening;
Arm pain; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 11:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patients' medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 at 11:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Apr2021, the patient experienced arm pain and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm pain and fatigue were not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
The swelling did not go down and I was left with a huge, hurting, and itching bump. I was told that it was a site reaction. I was instructed to use an ice pack on it for 15 mins every hour or so and to take Benadryl and Tylenol.
Mom noticed 1/13/07 (Sunday) swelling left arm - some irritation Redness induration about 8x9cm no fever.
Tingling around lips in addition to being light headed. Tingling around lips began within an hour and has lasted for more than 24 hours. Skin on lower face has also been itchy (chin, cheeks). This developed later in the day and has persisted for more than 24 hours. Feels similar to when I had a reaction to Niacin.
Pt. calls clinic c/o H/A, mm-aches, fever, chills throughout night approximately then at 12 noon 10/9/13 - pt states he has had stomach pain and diarrhea. 430pm not feeling better re: fever/chills, no more diarrhea.
chronic spontaneous urticarial rash I have been taking allergra and hydrocortisone ointment. Allergy pills only help for 24hrs and then another rash develops.
Information was received from a registered nurse, who reported that on multiple unspecified dates, multiple unspecified patients were administered improperly stored PROQUAD (lot #M014302, expiration date 22-SEP-2017) (albumin status, dosage and route of administration not provided). No adverse effects reported. Temperature/Time frame: > 14°F but < 46°F for 3 hours. Previous temperature excursion (date unknown): > 14°F but < 46°F for 5 hours. No additional information provided. Additional information has been requested. Sender's Comments: US-009507513-1702USA012015: US-009507513-1702USA012016: US-009507513-1702USA009271.
102 degree fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102 degree fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (102 degree fever). At the time of the report, PYREXIA (102 degree fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degree (High) 102 degree.         The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported     Reporter did not allow further contact
A little over a week after receiving my first COVID vaccine, I discovered a large round, red spot at the injection site in my right arm. It did itch a little, but not much. Was not sore. The next day (3/7/21), I started itching on the left side of my neck. When I looked in the mirror, I had a large, red rash. I put some Calehyst on it to stop the itching.
Feeling of skin being "itchy" from the inside; Flushing of skin all over body but no rash; Chills; Headache; This is a spontaneous report received from a contactable other healthcare professional (patient). A 44-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/lot number: Not Reported, Expiry Date: Not Reported), via an unspecified route of administration, administered in Arm Left on 22Apr2021 (at the age of 44-year-old) at 09:15 as dose 1, single for COVID-19 immunisation at Clinic/facility. The patient was not pregnant at the time of vaccination. The patient medical history included systemic lupus erythematosus, nephritis, raynaud's phenomenon, psoriasis, psoriatic arthritis, type 2 diabetes mellitus. The patient concomitant medication(s) included bupropion hydrochloride (WELLBUTRIN), naltrexone (NALTREXONE), Plaquenil, and Effexor XR taken for an unspecified indication, start and stop date were not reported. The patient received this medication within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. The patient previously took sulfonamide and experienced drug hypersensitivity (known allergies Sulfa based medications). On 22Apr2021 at 10:30, the patient experienced, feeling of skin being itchy from the inside, flushing of skin all over body but no rash, chills, and headache. The patient did not receive any treatment for the reported events. Outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected
swelling of the injection site; feels like a bee sting; area around the injection site was hard,red and swollen; area around the injection site was hard,red and swollen; tingling of arm/shoulder; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swelling of the injectionsite), PAIN (feels like a bee sting), VACCINATION SITE ERYTHEMA (area around the injection site was hard,red and swollen), INJECTION SITE INDURATION (area around the injection site was hard,red and swollen) and PARAESTHESIA (tingling of arm/shoulder) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 14-Apr-2021, the patient experienced PARAESTHESIA (tingling of arm/shoulder).  On an unknown date, the patient experienced INJECTION SITE SWELLING (swelling of the injectionsite), PAIN (feels like a bee sting), VACCINATION SITE ERYTHEMA (area around the injection site was hard,red and swollen) and INJECTION SITE INDURATION (area around the injection site was hard,red and swollen).   At the time of the report,  INJECTION SITE SWELLING (swelling of the injectionsite), PAIN (feels like a bee sting), VACCINATION SITE ERYTHEMA (area around the injection site was hard,red and swollen) and INJECTION SITE INDURATION (area around the injection site was hard,red and swollen) outcome was unknown. The outcome for the event PARAESTHESIA (tingling of arm/shoulder) was not recovered.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Right after the vaccine I felt a little funny. Within 10 minutes of receiving the vaccine I started coughing, lost my voice, Itchy eyelids, my chest was pounding, and overall just did not feel right. EMS Took my blood pressure and it was 255, then they waited a smidge and decided to give me an injection of Benadryl, within 10 minutes of the Benadryl my blood pressure went down to 225, and I overall felt a little bit better. My eyelids were still swollen and itchy and I didn?t have a voice, they took my blood pressure again and it went down to 218. They stayed with me. I was starting to feel a little bit better. My blood pressure went down to 180 and there?s no wheezing in my chest. They let me leave shortly after that. I still do not have a voice. My eyelids are still swollen slightly and very itchy and my lips tingle.
Redness, swelling, warmth, and itchiness starting 7 days after vaccination.